Home▸Articles▸Newborn Metabolic Screening

SCID Newborn Screening: The Role of T-Cell Receptor Excision Circles

A critical diagnostic tool for early detection and treatment of severe combined immunodeficiency.

mysimulator teamUpdated June 2026≈ 3 min read▶ Open the simulation

What are T-Cell Receptor Excision Circles

T-Cell Receptor Excision Circles (TRECs) are circular DNA molecules found in the thymus, which is a primary site for T-cell development. TRECs are generated during the process of T-cell receptor rearrangement, where non-functional or potentially harmful T-cells are eliminated through a mechanism known as allelic exclusion.

The presence and number of TRECs can be used to assess the function and health of the thymus, which is crucial for the development of a competent immune system. In individuals with severe combined immunodeficiency (SCID), the thymus fails to produce enough functional T-cells, leading to a decrease in TRECs.

How TRECs are Detected

Detection of TRECs involves a quantitative PCR (qPCR) assay that amplifies specific sequences within the TRECs. This method allows for the accurate measurement of TREC levels, which can then be compared to reference values established in healthy individuals.

The qPCR technique is highly sensitive and specific, making it an ideal tool for newborn screening programs where early detection can significantly improve patient outcomes.

live demo · related simulation● LIVE

Why TRECs Matter

TRECs serve as a biomarker for T-cell development and function. Their presence or absence is indicative of the thymus's ability to produce functional T-cells, which are essential for adaptive immunity.

By identifying newborns with low levels of TRECs through screening programs, healthcare providers can initiate timely interventions such as bone marrow transplantation or enzyme replacement therapy, potentially saving lives and improving quality of life.

Real-World Applications

The use of TRECs in newborn screening has revolutionized the approach to diagnosing SCID. Early detection allows for prompt treatment, which can prevent severe infections and other complications associated with this condition.

This technique not only improves patient outcomes but also reduces healthcare costs by preventing long-term hospitalizations and treatments.

Frequently asked questions

How accurate is the TREC screening method?

The qPCR-based TREC assay is highly accurate, with a sensitivity and specificity that approaches 100%. This makes it an excellent tool for newborn screening programs.

Can TRECs be detected in adults as well?

Yes, TRECs can also be detected in adults. However, their levels are typically much lower than in infants and may not be as useful for diagnosing SCID in older individuals.

What happens if a newborn screens positive for low TREC levels?

If a newborn screens positive, further diagnostic tests such as flow cytometry or genetic testing are performed to confirm the diagnosis of SCID and determine the appropriate treatment plan.

Is TREC screening available in all countries?

The availability of TREC screening varies by country. Some regions have implemented newborn screening programs for SCID, while others may not yet offer this service due to resource constraints or lack of awareness.

Try it live

Everything above runs in your browser — open SCID Newborn Screening T-Cell Receptor Excision Circle and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.

▶ Open SCID Newborn Screening T-Cell Receptor Excision Circle simulation

What did you find?

Add reproduction steps (optional)